U.S. Home Infusion Therapy market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million.
Selbyville, United States – July 24, 2019 —
U.S. Home Infusion Therapy Market size is set to exceed USD 13.5 billion by 2024; according to a new research report by Global Market Insights.
Increasing rates of hospital-acquired infections have impacted market growth positively. In American hospitals, infections associated with health care account for around 1.7 million infections and 99,000 deaths every year. These infections lead to chronic diseases that require continuous monitoring; thus, accelerate demand for home infusion therapies.
The U.S. home infusion therapy market has emerged as an opportunistic business landscape lately, not only for numerous pharma companies but also for healthcare service providers. In the U.S., patients suffering from infections, immune disorders, gastrointestinal diseases, and cancer & cancer-related problems are giving preference for home infusion therapy, owing to the comfort and cost-effectiveness associated with this line of treatment. More precisely, the chances of healthcare-acquired infections are lesser in the patients treated with home infusion therapy. The enhanced health safety concerns among the American masses is thus a prominent driver stimulating U.S. home infusion therapy industry trends.
U.S. Home Infusion Therapy Market size was valued at around USD 7 billion in 2017 and is expected to witness more than 10% CAGR from 2018 to 2024.
Get a Sample Copy of this Report@ https://www.gminsights.com/request-sample/detail/2641
It has been observed that most of the Medicare Advantage health plans and private insurers have recognized that this therapy could come under comprehensive coverage, owing to its clinical effectiveness and affordability. The probable chances of inclusion of this therapy in Medicare coverage policies are further likely to augment U.S. home infusion therapy market outlook over the years ahead.
Hospitals, home health agencies, and retail pharmacies have been extensively proactive about providing treatment to the geriatric populace suffering from serious illnesses. In fact, they are also educating patients about therapies so that they are in a position to administer treatment by themselves. As of now, in the U.S., the FDA has approved a range of home infusion therapies to treat numerous ailments. Some of these therapies have been adopted extensively across the nation, propelling U.S. home infusion therapy industry share.
Though the rate of cancer prevalence across U.S. has decreased gradually with the deployment of advanced treatment facilities related to early diagnosis, the mortality rate is not under control. As per the estimates of the National Cancer Institute, in 2018, among 1,735,350 probable new cancer cases in the U.S., 609,640 are likely to succumb to the disease. Amidst this grim scenario, it has also been observed that most of the cancer patients prefer receiving chemotherapy at their homes rather than going to the hospital. The major factor for this shift of preference is to reduce the number of visits to hospitals and receive treatments in a comfort zone. Consequently, home-based chemotherapies are remarkably fueling the demand for home medical equipment, generating a profitable avenue for U.S. home infusion therapy market growth.
Home infusion therapy specialty programs are lately on a rise across the U.S. and myriad other countries. It has been observed that in patients with gastrointestinal and chronic diseases, nutrient absorption is pivotal hinderance. In this regard, many physicians and pharmacists have developed a nutritional compound known as Total Parenteral Nutrition. This nutritional compound comprises carbohydrates, electrolytes, fats, vitamins, protein, and electrolytes, which can be used to accomplish the comprehensive nutritional need of patients. For the record, in U.S. nearly 40,000 people receive parenteral nutrition for treating the gastrointestinal disorders. The escalating requirement of parenteral nutrition is thus slated to propel U.S. home infusion therapy market share considerably.
Browse Report Summary @ https://www.gminsights.com/industry-analysis/us-home-infusion-therapy-market
As pharmacists, healthcare regulators, and healthcare research centers are extending their approach toward home infusion therapy, U.S. home infusion industry is emerging as a lucrative business vertical in the global healthcare space. The implementation of home infusion therapies in chemotherapy, intravenous antibiotics, total pain management medications, growth hormones, and parenteral nutrition will precisely endorse U.S. home infusion therapy market size, owing to their growing adoption. As per statistics, with the escalating acceptance of home-based health facilities, U.S. home infusion therapy market will generate a revenue of more than USD 13.5 billion by the end of 2024.
Chapter 1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
22.214.171.124. Paid sources
126.96.36.199. Unpaid sources
Chapter 2. Executive Summary
2.1. U.S. Home Infusion Therapy industry 3600 synopsis, 2013 – 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Regional trends
Chapter 3. U.S. Home Infusion Therapy Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
188.8.131.52. Growing hospital acquired infections
184.108.40.206. Rising prevalence of chronic diseases
220.127.116.11. Advancements in technology
18.104.22.168. Growing geriatric population
22.214.171.124. Presence of homecare facilities
3.3.2. Industry pitfalls & challenges
126.96.36.199. Dearth of reimbursement
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By application
3.5. Regulatory landscape
3.6. Porter’s analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. U.S. Home Infusion Therapy Market, By Product
4.1. U.S. Home Infusion Therapy market share, by product, 2017 & 2024
4.2. Infusion pumps
4.2.1. Market estimates and forecast, by region, 2013 – 2024
4.3. Intravenous sets
4.3.1. Market estimates and forecast, by region, 2013 – 2024
4.4. IV cannulas
4.4.1. Market estimates and forecast, by region, 2013 – 2024
4.5. Needleless connectors
4.5.1. Market estimates and forecast, by region, 2013 – 2024
More info about U.S. Home Infusion Therapy Market@ https://www.marketwatch.com/press-release/new-study-predicts-growth-in-us-home-infusion-therapy-market-135-bn-by-2024-2019-02-26
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Name: Arun Hegde
Email: Send Email
Organization: Global market insights
This content is not produced by Reuters Editorial News. It is produced by VC NewsNetwork. For content enquiry, please reach us at
The store management software firm has received backing from Jungle Ventures and Traveloka.
The Business Times first reported on the startup’s successful seed round funding on Tuesday.
Hungry Hub app offers a fixed-price buffet dining service that focuses on a la carte eateries.
Following the deal, Hashmeta will integrate content generated from its influencer network platform StarNgage into ShopperBoard.
The funding will be used for business support and expansion into other Southeast Asia countries.